Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra’s phase 3 pivotal safety study for oral weekly risperidone ...

An investigational, weekly oral dose of risperidone for schizophrenia achieved drug levels comparable to daily Risperdal in a phase 3 study involving Lynx, a long-acting drug delivery platform ...

Teva is offering a generic version Risperdal Consta Long-Acting Injection. The generic name is Risperidone for Extended-Release Injectable Suspension.

In the present study, our aim was twofold. Firstly, to examine the response to atypical antipsychotic treatment (risperidone) in deletion carriers. Secondly, to investigate the short- and long-term ...

J&J settles most Risperdal lawsuits, with $800 million in expenses J&J said in a filing with the U.S. Securities and Exchange Commission on Friday that it reached a settlement in principle in ...

J ohnson & Johnson JNJ says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million in expenses in connection with the agreement. The medical ...

Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed ...

BOSTON — Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and ...

An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of risperidone over 1-week dosing intervals, according to results of a randomized, parallel ...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia ...